Literature DB >> 29409809

Crosstalk between the Notch signaling pathway and long non-coding RNAs.

Andreas Reicher1, Johannes Foßelteder2, Lawrence N Kwong3, Martin Pichler4.   

Abstract

The Notch signaling pathway has a key role in cellular development and is involved in initiation and progression of cancer by fundamentally influencing cellular processes such as differentiation, proliferation or migration. The pathway is regulated on many stages, generating diverse outcomes depending on cellular context or signaling dose. Recent studies suggest that long non-coding RNAs (lncRNAs), a class of non-coding RNAs deregulated in many cancers, are involved in regulating the Notch pathway activity by modulating the expression of receptors or ligands on transcriptional or posttranscriptional levels. LncRNAs are also downstream targets of Notch signaling and some of these Notch-induced lncRNAs have been reported to be inducers of its oncogenic effects. This cross-talk between Notch signaling and lncRNAs makes those molecules potential biomarkers for Notch signaling activity and interesting therapeutic RNA-based targets in the future.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; Long non-coding RNA; Notch signaling pathway

Mesh:

Substances:

Year:  2018        PMID: 29409809     DOI: 10.1016/j.canlet.2018.01.070

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  The crosstalk between long non-coding RNAs and the hedgehog signaling pathway in cancer.

Authors:  Marzieh Lotfian Sargazi; Saeideh Jafarinejad-Farsangi; Maryam Moazzam-Jazi; Farzaneh Rostamzadeh; Zahra Miri Karam
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 2.  Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway.

Authors:  Angelo Giuseppe Condorelli; May El Hachem; Giovanna Zambruno; Alexander Nystrom; Eleonora Candi; Daniele Castiglia
Journal:  J Biomed Sci       Date:  2021-05-09       Impact factor: 8.410

Review 3.  Targeting PI3K in cancer: mechanisms and advances in clinical trials.

Authors:  Jing Yang; Ji Nie; Xuelei Ma; Yuquan Wei; Yong Peng; Xiawei Wei
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

Review 4.  Involvement of the long noncoding RNA NEAT1 in carcinogenesis.

Authors:  Christiane Klec; Felix Prinz; Martin Pichler
Journal:  Mol Oncol       Date:  2018-12-03       Impact factor: 6.603

Review 5.  Role of Long Non-Coding RNA LINC00641 in Cancer.

Authors:  Xue Han; Shitai Zhang
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

Review 6.  Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.

Authors:  Omnia Emam; Eman F Wasfey; Nadia M Hamdy
Journal:  Cancer Cell Int       Date:  2022-10-13       Impact factor: 6.429

7.  Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway.

Authors:  Lan Xiao; Xiao Yan Shi; Ze Lian Li; Min Li; Min Min Zhang; Shi Jie Yan; Zhao Lian Wei
Journal:  J Gynecol Oncol       Date:  2021-06-10       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.